These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8109209)

  • 1. Increased lenticular aldose reductase activity and high incidence of congenital cataract in the offspring of diabetic rats.
    Simán CM; Naeser P; Eriksson UJ
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):629-36. PubMed ID: 8109209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y; Kador PF; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase and sorbitol dehydrogenase distribution in substructures of normal and diabetic rat lens.
    Collins JG; Corder CN
    Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):242-3. PubMed ID: 403152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation.
    Zhang P; Xing K; Randazzo J; Blessing K; Lou MF; Kador PF
    Exp Eye Res; 2012 Aug; 101():36-43. PubMed ID: 22710095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of lens aldose reductase activity by nitric oxide.
    Srivastava S; Tammali R; Chandra D; Greer DA; Ramana KV; Bhatnagar A; Srivastava SK
    Exp Eye Res; 2005 Dec; 81(6):664-72. PubMed ID: 15967436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase expression as a risk factor for cataract.
    Snow A; Shieh B; Chang KC; Pal A; Lenhart P; Ammar D; Ruzycki P; Palla S; Reddy GB; Petrash JM
    Chem Biol Interact; 2015 Jun; 234():247-53. PubMed ID: 25541468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on cataractogenesis in humans and in rats with alloxan-induced diabetes. II. Histochemical evaluation of lenticular enzymes.
    Ahmad SS; Tsou KC; Ahmad SI; Rahman MA
    Ophthalmic Res; 1985; 17(1):12-20. PubMed ID: 2984623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reinvestigation of streptozotocin induced diabetic cataract as a standard experimental model].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1993 Mar; 97(3):324-32. PubMed ID: 8317349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonosmotic diabetic cataracts.
    Malone JI; Lowitt S; Cook WR
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
    Sankeshi V; Kumar PA; Naik RR; Sridhar G; Kumar MP; Gopal VV; Raju TN
    J Ethnopharmacol; 2013 Aug; 149(1):215-21. PubMed ID: 23827758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.
    Ashizawa N; Yoshida M; Sugiyama Y; Akaike N; Ohbayashi S; Aotsuka T; Abe N; Fukushima K; Matsuura A
    Jpn J Pharmacol; 1997 Feb; 73(2):133-44. PubMed ID: 9074947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of insulin on aldose reductase activity in the lens of rats with streptozotocin-induced diabetes].
    Nishigami T
    Nippon Ganka Gakkai Zasshi; 1990 Feb; 94(2):128-34. PubMed ID: 2114733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase.
    Jedziniak JA; Chylack LT; Cheng HM; Gillis MK; Kalustian AA; Tung WH
    Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):314-26. PubMed ID: 6782033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
    Kubo E; Maekawa K; Tanimoto T; Fujisawa S; Akagi Y
    Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lenses.
    Chylack LT; Henriques HF; Cheng HM; Tung WH
    Ophthalmology; 1979 Sep; 86(9):1579-85. PubMed ID: 121768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical Evidence Indicates the Preventive Effect of Resveratrol and Nicotinamide in the Treatment of STZ-induced Diabetic Cataract.
    Singh A; Bodakhe SH
    Curr Eye Res; 2021 Jan; 46(1):52-63. PubMed ID: 32631099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats.
    Kawakubo K; Mori A; Sakamoto K; Nakahara T; Ishii K
    Biol Pharm Bull; 2012; 35(6):866-72. PubMed ID: 22687477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative defense enzyme activity and mRNA levels in lenses of diabetic rats.
    Khanna P; Wang L; Perez-Polo RJ; Ansari NH
    J Toxicol Environ Health; 1997 Aug; 51(6):541-55. PubMed ID: 9242227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.